BioSpace News Archive

The experimental drug, if approved, will compete with GlaxoSmithKline’s Benlysta, which is the only new drug approved for lupus in the last 60 years.

Researchers found neurons may shut down without dying and these “undead neurons” release molecules that shut down neighboring brain cells, which leads to the common Parkinson’s symptoms.

Eli Lilly is planning to seek another regulatory approval for Taltz after the medication hit the primary and secondary endpoints in a Phase III study for the treatment of non-radiographic axial spondyloarthritis.

Foster Corporation, a leader in polymer material solutions for the medical and pharmaceutical markets, received Arkema’s Legacy & Innovation Award at the recent K Show in Dusseldorf, Germany.

Ellume Limited is pleased to announce the appointment of Ms Joanne Moss to its Board as an Independent Non-Executive Director and Chair of Audit and Risk, effective immediately.

Brisbane biotech Microba were chosen to participate in international pitching competition, the Falling Walls Venture in Berlin, based on their world-leading work in analysing gut bacteria.

Biocon Ltd announced that it has been recognised as the ASIA IP ELITE for the fourth year in a row and its wholly-owned subsidiary Biocon Biologics makes its debut on this prestigious list in 2019 by the IP Business Congress Asia for robust Intellectual Property management and consistent IP value creation.

In its announcement, Solid Biosciences said a patient in its second cohort who was dosed in October experienced a serious adverse event that was deemed related to the drug.

Medical and health service managers work hard to improve the quality and efficiency required to deliver first rate healthcare services.

For BioSpace’s recent Ideal Employer report, life sciences professionals weighed in on the topic.